Cetilistat | CAS:282526-98-1

We serve Cetilistat CAS:282526-98-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Cetilistat

Chemical Name:Cetilistat
CAS.NO:282526-98-1
Synonyms:Cetilistat
2-Hexadecyloxy-6-methyl-4H-3,1-benzoxazin-4-one
2-(Hexadecycloxy)-6-methyl-4H-3,1-benzoxazin-4-one
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 509.7±43.0 °C at 760 mmHg
Molecular Formula C25H39NO3
Molecular Weight 401.582
Flash Point 158.9±22.6 °C
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.521
 
Specification:
Appearance:Gray-white crystalline powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Cetilistat is a drug designed to treat obesity. It acts in the same way as the older drug orlistat(Xenical) by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. Without this enzyme, triglycerides from the diet are prevented from being hydrolyzed into absorbable free fatty acids and are excreted undigested.



Contact us for information like Nicotinamide riboside chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(Hexadecycloxy)-6-methyl-4H-3,1-benzoxazin-4-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Nicotinamide riboside chloride Use and application,Nicotinamide riboside chloride technical grade,usp/ep/jp grade.


Related News: But they’ll be subject to up to 14 days of mandatory quarantine once they’re back in the US.1,3-Dibromo-2-propanol manufacturer This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.2',3'-Dideoxyguanosine supplier “We believe such actions are our last resort,” the Hospital Authority Employees Alliance, a union that formed during the city’s antigovernment protest movement, wrote in a statement.2,3-Difluorobenzotrifluoride vendor With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.